Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
393.84B | 247.64B | 130.56B | 93.95B | 59.49B | Gross Profit |
239.94B | 155.92B | 99.10B | 62.23B | 40.21B | EBIT |
108.42B | 58.70B | 30.40B | 6.90B | -9.38B | EBITDA |
109.21B | 59.48B | 39.21B | 12.53B | -8.73B | Net Income Common Stockholders |
112.43B | 60.03B | 31.54B | 7.77B | -7.33B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
331.56B | 217.21B | 149.44B | 92.94B | 86.97B | Total Assets |
505.03B | 348.08B | 237.12B | 181.21B | 158.91B | Total Debt |
10.61B | 10.17B | 16.93B | 12.76B | 16.97B | Net Debt |
-47.16B | -49.63B | -17.39B | 6.33B | -5.45B | Total Liabilities |
191.72B | 160.84B | 119.35B | 106.10B | 98.73B | Stockholders Equity |
313.31B | 187.24B | 117.77B | 75.11B | 60.18B |
Cash Flow | Free Cash Flow | |||
121.93B | 93.58B | 6.40B | 25.50B | 28.15B | Operating Cash Flow |
121.93B | 94.16B | 7.03B | 28.78B | 28.20B | Investing Cash Flow |
-118.36B | -55.43B | -3.24B | -35.56B | -38.36B | Financing Cash Flow |
1.16M | -8.96B | 1.46M | -1.88B | 51.80B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
83 Outperform | $303.69B | 16.39 | 11.97% | 0.84% | 4.28% | 28.42% | |
78 Outperform | $157.86B | 9.87 | 45.06% | ― | 57.51% | 82.28% | |
78 Outperform | $62.78B | 9.85 | 17.55% | 2.01% | 5.20% | 77.60% | |
78 Outperform | $68.95B | 142.71 | 5.93% | ― | 28.46% | 185.04% | |
74 Outperform | $98.63B | 48.85 | 51.50% | ― | 43.56% | 91.72% | |
59 Neutral | $38.75B | 241.98 | 3.76% | ― | 24.14% | -88.77% | |
59 Neutral | $11.22B | 10.13 | -1.22% | 3.96% | 1.32% | -18.57% |